|
|
|
|
| LEADER |
03477nam a22004695i 4500 |
| 001 |
978-0-387-71996-2 |
| 003 |
DE-He213 |
| 005 |
20151204172632.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2007 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387719962
|9 978-0-387-71996-2
|
| 024 |
7 |
|
|a 10.1007/978-0-387-71996-2
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RA1-1270
|
| 072 |
|
7 |
|a MBN
|2 bicssc
|
| 072 |
|
7 |
|a MED078000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 613
|2 23
|
| 082 |
0 |
4 |
|a 614
|2 23
|
| 100 |
1 |
|
|a Schlander, Michael.
|e author.
|
| 245 |
1 |
0 |
|a Health Technology Assessments by the National Institute for Health and Clinical Excellence
|h [electronic resource] :
|b A Qualitative Study /
|c by Michael Schlander.
|
| 264 |
|
1 |
|a New York, NY :
|b Springer New York,
|c 2007.
|
| 300 |
|
|
|a XXX, 245 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Innovation and Valuation in Health Care
|
| 505 |
0 |
|
|a A Note on Objectives and Methods -- NICE Appraisal Process -- NICE Appraisal of ADHD Treatments -- NICE Appraisal of ADHD Treatment Options: A Critique -- Discussion and Implications -- Which Way Forward?.
|
| 520 |
|
|
|a First in a new series on economic issues in the context of health care policy, Health Technology Assessments by the National Institute for Health and Clinical Excellence examines Britain’s highly acclaimed approach to cost-effectiveness analysis (CEA), and its international potential. The National Institute for Health and Clinical Excellence (NICE) has been regarded as a role model for the implementation of CEA, and is being closely watched by health care policy makers throughout Europe, and in the United States. This volume dissects the robustness of the agency’s technology appraisal processes as NICE evaluates innovative methods for diagnosis and intervention. Given the unique features of attention-deficit/hyperactivity disorder (ADHD)—starting with it being diagnosed mainly in children and adolescents, its high comorbidity with other psychiatric conditions, and its considerable economic impact—the disorder is a perfect focal point for discussion. Review of clinical issues in ADHD, including diagnostic criteria and the use of psychostimulants. Step-by-step explanation of the NICE appraisal process: valuation of treatment strategies for ADHD. Successes and limitations of NICE: an in-depth critique. Future directions and implications for health care prioritization in other countries. Balanced clinical and economic perspectives throughout the book. This is salient reading for public health professionals in health service administration, research, policy, and economics. Whether one’s interest is the robustness of the NICE method, or its application across clinical conditions or delivery systems, this book is a singular look into the real world of health care decision-making.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Public health.
|
| 650 |
|
0 |
|a Health administration.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Public Health.
|
| 650 |
2 |
4 |
|a Health Administration.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9780387719955
|
| 830 |
|
0 |
|a Innovation and Valuation in Health Care
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-0-387-71996-2
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
